Ranibizumab and Bevacizumab for AMD REPLY

被引：0
|
作者：
Martin, Daniel F. [1 ]
Maguire, Maureen G. [2 ]
Fine, Stuart L. [3 ]
机构：
[1] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Univ Colorado Denver, Aurora, CO USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 365卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2237 / 2237
页数：1
相关论文
共 50 条
  • [1] Bevacizumab versus Ranibizumab for AMD
    Rosenfeld, Philip J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20): : 1966 - 1967
  • [2] Bevacizumab: as effective as ranibizumab for AMD, but safe?
    [J]. Reactions Weekly, 2012, 1404 (1) : 5 - 5
  • [3] Aflibercept for AMD patients treated unsuccessfully with Ranibizumab and Bevacizumab
    Pappas, George Dimitris
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [4] Lucentis (Ranibizumab) versus Avastin (Bevacizumab) for CNV/AMD
    Naomi, Fischer
    Rodrigo, Jung
    Gadi, Heilweil
    David, Varssano
    Michaella, Goldstein
    Adiel, Barak
    Anat, Loewenstein
    [J]. 8TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS - ISOPT, 2009, : 65 - 68
  • [5] Bevacizumab less costly, just as safe as ranibizumab in AMD
    [J]. Reactions Weekly, 2014, 1519 (1) : 12 - 12
  • [6] Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
    Cho, Hyung
    Shah, Chirag P.
    Weber, Marissa
    Heier, Jeffrey S.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (08) : 1032 - 1035
  • [7] Differences of frequency in administration of ranibizumab and bevacizumab in patients with neovascular AMD
    Scholler, Andreas
    Richter-Mueksch, Sibylla
    Weingessel, Birgit
    Vecsei-Marlovits, Pia-Veronika
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (11-12) : 355 - 359
  • [8] An ethical view of the ranibizumab and bevacizumab controversy - Reply
    Miller, Joan W.
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (02) : 286 - 287
  • [9] Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
    Maria Waizel
    Margarita G. Todorova
    Michael Masyk
    Katharina Wolf
    Annekatrin Rickmann
    Khaled Helaiwa
    Björn R. Blanke
    Peter Szurman
    [J]. BMC Ophthalmology, 17
  • [10] Ranibizumab and bevacizumab show equivalent effects on visual acuity in patients with neovascular AMD
    不详
    [J]. FORMULARY, 2011, 46 (06) : 203 - 203
12345